abstract |
The invention is directed to ginseng fractions and methods for the activation of innate and adaptive immune responses, to prevent, treat or lessen a condition in a subject by administering to the subject an effective amount of a ginseng fraction, a pharmaceutical composition comprising the fraction in combination with another medicine or with one or more pharmaceutically acceptable carriers, or a food item comprising the fraction. The fraction can be made from Panax quinquefolius, or it can be selected from CVT-E002, PQ2, PQ223 and purified fractions of CVT-E002, PQ2, PQ223. |